{
  "image_filename": "table_p8_det_7_002.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/table_p8_det_7_002.png",
  "image_type": "Table",
  "page_number": 8,
  "block_id": "det_7_002",
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "supports_claim": false,
  "explanation": "Table displaying primary and secondary clinical outcomes (e.g., PCR-confirmed influenza A and B, hospitalizations) comparing two vaccinated cohorts, with columns for cases per 1000, unadjusted rate ratios, adjusted hazard ratios with 95% CIs, vaccine effectiveness percentages, and P values. The table presents clinical effectiveness and outcome data and does not mention or describe any vaccine production methods, so it does not support the claim.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table displaying primary and secondary clinical outcomes (e.g., PCR-confirmed influenza A and B, hospitalizations) comparing two vaccinated cohorts, with columns for cases per 1000, unadjusted rate ratios, adjusted hazard ratios with 95% CIs, vaccine effectiveness percentages, and P values.",
    "evidence_found": null,
    "reasoning": "The table presents clinical effectiveness and outcome data and does not mention or describe any vaccine production methods, so it does not support the claim.",
    "confidence_notes": null
  }
}